Business · 02/04/2018Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of Five New Drug Applications from Mallinckrodt Inc. and Other Applicants
Summary
Mallinckrodt Inc. and other applicants have had their FDA approval for five new drug applications withdrawn due to the drugs no longer being marketed, according to the FDA.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →